Fanny Elahi is a board-certified neurologist with specific expertise in the evaluation and management of patients with cognitive and behavioral disorders due to degenerative brain diseases such as Alzheimer's disease and related disorders. She completed her bachelor's degree at Columbia University, her MD from Icahn School of Medicine, at Mount Sinai, and her DPhil from Oxford University. She pursued her residency in neurology at the University of California, Los Angeles and joined the University of California, San Francisco Memory and Aging Center in 2015 where she trained in neurodegenerative disorders prior to joining the faculty in the department of Neurology. Her research is focused on the identification of early biomarkers of degenerative brain disease with a particular interest in characterization of contributions of immune dysregulation and vascular disease to brain dysfunction, mood and cognitive changes, and ultimately progressive brain degeneration. Her work has been supported by the American Academy of Neurology in partnership with the Allergan foundation, the Alzheimer's Disease Research Center at the UCSF Memory and Aging Center, the National Institute of Neurological Disorders and Stroke, as well as philanthropic donations.